Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma

References

• Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34:46–52.
   PubMed Web of Science ®Google Scholar
• Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988;94: 482–7.
   PubMed Web of Science ®Google Scholar
• Salerno F, Borroni G, Moser P, Badalamenti S, Cassara L, Maggi A, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993;88: 514–9.
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–9.
   PubMed Web of Science ®Google Scholar
• Eggel H. Uber das primëre Carcinom der Leber. Beitre Pathol Anat 1901;30:506–604.
   Google Scholar
• Tsuji Y, Koga S, Ibayashi H, Nose Y, Akazawa K. Prediction of the prognosis of liver cirrhosis in Japanese using Cox’s proportional hazard model. Gastroenterol Jpn 1987;22:599–606.
   Google Scholar
• Schlichting P, Christensen E, Andersen PK, Fauerholdt L, Juhl E, Poulsen H, et al. Prognostic factors in cirrhosis identified by Cox’s regression model. Hepatology 1983;3:889–95.
   PubMed Web of Science ®Google Scholar
• Christensen E. Multivariate survival analysis using Cox’s regression model. Hepatology 1987;7:1346–58.
   PubMed Web of Science ®Google Scholar
• Milani A, Marra L, Siciliano M, Rossi L. Prognostic significance of clinical and laboratory parameters in liver cirrhosis a multivariate statistical approach. Hepato-gastroenterology 1985; 32: 270–2.
   PubMedGoogle Scholar
• A Report from the Copenhagen Study Group for Liver Diseases. Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone. N Engl J Med 1974;291:271–3.
   Google Scholar
• Finucci G, Bellon S, Merkel C, Mormino P, Tirelli M, Gatta A, et al. Evaluation of splanchnic angiography as a prognostic index of survival in patients with cirrhosis. Scand J Gastroenterol 1991; 26:951–60.
   PubMed Web of Science ®Google Scholar
• Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7: 660–4.
   Google Scholar
• D’Amico G, Morabito A, Pagliaro L, Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986;31:468–75.
   Google Scholar
• Shear L, Kleinerman J, Cabuzda GJ. Renal failure in patients with cirrhosis of the liver. Am J Med 1965;39:184–98.
   Google Scholar
• Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers TC, Abrams HL, et al. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970;49:175–85.
   PubMed Web of Science ®Google Scholar
• Hampel H, Bynum GD, Zamora E, El-Serag HB. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol 2001;96:2206–10.
   Google Scholar
• Arroyo V, Bosch J, Gaya-Beltran J, Kravetz D, Estrada L, Rivera F, et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 1981;94:198–201.
   Google Scholar
• Arroyo V, Bosch J, Mauri M, Viver J, Mas A, Rivera F, et al. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites. Eur J Clin Invest 1979;9:69–73.
   PubMed Web of Science ®Google Scholar
• Cohn JN, Khatri IM, Groszmann RJ, Kotelanski B. Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technique. Am J Med 1972;53:704–14.
   PubMed Web of Science ®Google Scholar
• Groszmann R, Kotelanski B, Cohn JN, Khatri IM. Quantitationof portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease. Am J Med 1972;53:715–22.
   PubMed Web of Science ®Google Scholar
• Trewby PN, Williams R. Pathophysiology of hypotension in patients with fulminant hepatic failure. Gut 1977;18:1021–6.
   PubMed Web of Science ®Google Scholar
• Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993;18:353–8.
   PubMed Web of Science ®Google Scholar
• Deschenes M, Villeneuve JP. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol 1999;94:2193–7.
   PubMed Web of Science ®Google Scholar
• Kravetz D, Bildozola M, Argonz J, Romero G, Korula J, Munoz A, et al. Patients with ascites have higher variceal pressure and wall tension than patients without ascites. Am J Gastroenterol 2000;95:1770–5.
   PubMed Web of Science ®Google Scholar
• Luca A, Cirera I, Garcia-Pagan JC, Feu F, Pizcueta P, Bosch J, et al. Hemodynamic effects of acute changes in intra-abdominal pressure in patients with cirrhosis. Gastroenterology 1993;104: 222–7.
   Google Scholar
• Kravetz D, Romero G, Argonz J, Guevara M, Suarez A, Abecasis R, et al. Total volume paracentesis decreases variceal pressure, size, and variceal wall tension in cirrhotic patients. Hepatology 1997;25:59–62.
   PubMedGoogle Scholar
• Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology 1997;25:63–70.
   Google Scholar
• Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999;31:133–41.
   PubMed Web of Science ®Google Scholar
• Lerose R, Molinari R, Rocchi E, Manenti F, Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer 2001;37:239–45.
   Google Scholar
• The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74:2772–80.
   PubMedGoogle Scholar
• Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol 2001;96:1243–50.
   Google Scholar
• Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132–7.
   PubMed Web of Science ®Google Scholar
• Shijo H, Okazaki M. Prediction of portal vein invasion by hepatocellular carcinoma: a correlations between portal vein tumor thrombus and biochemical tests. Jpn J Clin Oncol 1991; 21:94–9.
   PubMedGoogle Scholar
• Yamakado K, Tanaka N, Nakatsuka A, Matsumura K, Takase K, Takeda K. Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein. J Hepatol 1999;30:660–8.
   PubMedGoogle Scholar
• Cillo U, Bassanello M, Vitale A, Grigoletto FA, Burra P, Fagiuoli S, et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 2004;40:124–131.
   PubMed Web of Science ®Google Scholar
• Maeda M, Koyama W, Sato C, Marumo F, Kanayama M, Uchida T. Hepatocellular carcinoma producing universal type ofalkaline phosphatase. Dig Dis Sci 1993;38:757–61.
   PubMedGoogle Scholar